As their 1-year anniversary with Mtech Access approaches, Medi Stone and William Muckley share their experiences of starting careers as Systematic Review Analysts in our Evidence Generation team. What...
Read More
Shona Lang (Senior Consultant – Systematic Reviews) comments on a recent article in BMJ Evidence-Based Medicine on ‘The need for clinical judgement in the application of evidence-based medicine’1. Having worked...
Read More
Mtech Access attended the virtual World Pharma Pricing Market Access & Evidence Congress on 23–25th September 2020, where our team were inspired by the range of seminars, round tables and...
Read More
We are delighted to announce that Mtech Access has been accepted as a corporate member of the British Healthcare Business Intelligence Association (BHBIA). At Mtech Access, we support our pharma...
Read More
Éanna Connaughton, Senior Medical Writer shares his experiences and perspectives of advisory boards, and highlights some of the other options we offer for those seeking insight from healthcare providers (HCPs). ...
Read More
Partitioned survival analysis (PartSA) is currently the most commonly used modelling approach within HTA (health technology assessment) for advanced or metastatic cancers. However, until recently, there was no formal documentation…
‘Time to event’ or ‘survival’ is an important endpoint used in efficacy assessments of medical interventions, particularly in disease areas such as oncology. The Cox proportional hazards (PH) model is…
Continuous outcomes data from trials may be categorised using pre-defined cut-offs to generate ordered categorical outcomes data. Usually the percentage of patients who have improved by certain thresholds are reported…
Network meta-analysis (NMA) is a key tool for researchers and decision makers that allows the efficacy and safety of any number of healthcare interventions to be compared simultaneously. However, a…